article thumbnail

LifeArc’s £40m research centres to boost research into rare diseases

Drug Discovery World

The centres will bring together scientists and rare disease clinical specialists from across the UK; encouraging new collaborations across different research disciplines and providing improved access to facilities and training. However, rare disease research can be fragmented. The £9.4 ($11.7) The new £9.4 ($11.7)

Research 130
article thumbnail

Research uncovers how to target dormant breast cancer cells

Drug Discovery World

Their research, published in the journal Cancer Discovery , reveals the role of epigenetics in controlling how cancer cells can become dormant – and suggests a strategy to target it before the cells wake up. They also found that in people with low expression of these enzymes, their cancer had a lower risk of coming back years later.

Research 264
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Meet the researcher: Dr Henrik Jespersen

Drug Discovery World

The neoadjuvant concept has become an ideal platform for both drug discovery and translational research. MT: What industry-wide drug discovery breakthrough has most impacted your research? DDW Volume 25 – Issue 2, Spring 2024 The post Meet the researcher: Dr Henrik Jespersen appeared first on Drug Discovery World (DDW).

Research 147
article thumbnail

$20 million donation supports neurodegeneration research

Drug Discovery World

The University of Texas MD Anderson Cancer Center has been awarded $20 million to strengthen neurodegeneration research. Driven by unparalleled proximity to patients and unmatched clinical and research expertise, Therapeutics Discovery and the BNDC can advance effective new therapies in ways not possible elsewhere.

Research 130
article thumbnail

Deliver Fast, Flexible Clinical Trial Insights with Spotfire

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management.

article thumbnail

Research reveals an immune cell that can kill all cancers

Drug Discovery World

Researchers in the US have discovered that a type of immune cell in the human body known to be important for allergy and other immune responses can also attack cancer. In previous research focused on mouse cells, ILC2s had not consistently shown promise when tested for their cancer-killing abilities.

Research 289
article thumbnail

UK dementia research gets £49.9 million funding boost

Drug Discovery World

Head of clinical trials at the University College London (UCL) Dementia Research Centre, Dr Cath Mummery, has been announced as the Director of a new network of dementia trial sites across the country. The post UK dementia research gets £49.9 The UK government has authorised £49.9 ($63.4)

Research 250